Article
Utility of recombinant proteins LID-1 and PADL in screening for Mycobacterium leprae infection and leprosy
7 Jun 2014
Abstract excerpt
BACKGROUND: Despite the widespread use of multidrug therapy, leprosy remains an important public health concern in many regions. Detection is generally limited to clinical exam. METHODS: As a two-tiered active case finding strategy, we used the LID-1 (leprosy IDRI diagnostic-1), and PADL (protein advances for the diagnosis of leprosy) antigens for serological examination of 2526 individuals randomly selected from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
